US Stock MarketDetailed Quotes

ENTA Enanta Pharmaceuticals

Watchlist
  • 12.370
  • -0.110-0.88%
Close Apr 26 16:00 ET
  • 12.370
  • 0.0000.00%
Post 16:20 ET
261.70MMarket Cap-1882P/E (TTM)

Enanta Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
(Q3)Jun 30, 2022
(Q2)Mar 31, 2022
Total revenue
-23.67%18M
-8.07%79.2M
-6.82%18.93M
-3.01%18.89M
-4.92%17.8M
-14.70%23.59M
-11.24%86.16M
-13.82%20.32M
-9.92%19.48M
-7.03%18.72M
Operating revenue
-23.67%18M
-8.07%79.2M
-6.82%18.93M
-3.01%18.89M
-4.92%17.8M
-14.70%23.59M
-11.24%86.16M
-13.82%20.32M
-9.92%19.48M
-7.03%18.72M
Cost of revenue
Gross profit
Operating expense
-1.32%52.89M
3.05%216.41M
5.48%49.96M
6.89%55.61M
8.91%57.25M
-7.68%53.6M
1.62%210M
-17.34%47.37M
-6.22%52.02M
5.48%52.56M
Selling and administrative expenses
30.10%16.52M
16.28%52.89M
9.75%13.8M
-2.41%12.62M
31.52%13.78M
33.53%12.7M
39.79%45.48M
50.42%12.57M
52.52%12.93M
25.82%10.48M
-General and administrative expense
30.10%16.52M
16.28%52.89M
9.75%13.8M
-2.41%12.62M
31.52%13.78M
33.53%12.7M
39.79%45.48M
50.42%12.57M
52.52%12.93M
25.82%10.48M
Research and development costs
-11.08%36.37M
-0.61%163.52M
3.94%36.17M
9.97%42.99M
3.28%43.47M
-15.75%40.9M
-5.51%164.52M
-28.91%34.8M
-16.82%39.09M
1.40%42.09M
Operating profit
-16.24%-34.89M
-10.79%-137.21M
-14.72%-31.03M
-12.82%-36.71M
-16.56%-39.45M
1.30%-30.01M
-13.02%-123.84M
19.80%-27.05M
3.86%-32.54M
-13.96%-33.85M
Net non-operating interest income expense
-13.70%857K
294.91%6.21M
139.78%1.51M
375.57%1.87M
620.39%1.84M
993K
-22.17%1.57M
631K
393K
255K
Non-operating interest income
332.83%4.3M
622.19%11.36M
639.14%4.66M
883.72%3.87M
620.39%1.84M
--993K
-22.17%1.57M
--631K
--393K
--255K
Non-operating interest expense
--3.44M
--5.15M
--3.15M
--2M
----
--0
--0
--0
--0
----
Other net income (expense)
407.41%83K
Other non- operating income (expenses)
----
----
----
----
----
----
407.41%83K
----
----
----
Income before tax
-17.26%-34.03M
-7.21%-131M
-12.09%-29.52M
-8.39%-34.84M
-11.97%-37.61M
3.75%-29.02M
-13.58%-122.19M
21.14%-26.33M
3.77%-32.15M
-15.22%-33.59M
Income tax
-1,729.41%-622K
751.50%2.82M
-10,171.43%-1.41M
1,044.30%4.22M
44K
5.56%-34K
98.49%-433K
100.16%14K
95.24%-447K
0
Net income
-15.25%-33.41M
-9.91%-133.82M
-6.68%-28.11M
-23.23%-39.07M
-12.10%-37.66M
3.75%-28.99M
-54.13%-121.76M
-7.11%-26.35M
-31.95%-31.7M
-52.38%-33.59M
Net income continuous Operations
-15.25%-33.41M
-9.91%-133.82M
-6.68%-28.11M
-23.23%-39.07M
-12.10%-37.66M
3.75%-28.99M
-54.13%-121.76M
-7.11%-26.35M
-31.95%-31.7M
-52.38%-33.59M
Minority interest income
Net income attributable to the parent company
-15.25%-33.41M
-9.91%-133.82M
-6.68%-28.11M
-23.23%-39.07M
-12.10%-37.66M
3.75%-28.99M
-54.13%-121.76M
-7.11%-26.35M
-31.95%-31.7M
-52.38%-33.59M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-15.25%-33.41M
-9.91%-133.82M
-6.68%-28.11M
-23.23%-39.07M
-12.10%-37.66M
3.75%-28.99M
-54.13%-121.76M
-7.11%-26.35M
-31.95%-31.7M
-52.38%-33.59M
Basic earnings per share
-13.67%-1.58
-7.95%-6.38
-4.72%-1.33
-21.57%-1.86
-9.82%-1.79
6.08%-1.39
-50.77%-5.91
-4.10%-1.27
-28.57%-1.53
-49.54%-1.63
Diluted earnings per share
-13.67%-1.58
-7.95%-6.38
-4.72%-1.33
-21.57%-1.86
-9.82%-1.79
6.08%-1.39
-50.77%-5.91
-4.10%-1.27
-28.57%-1.53
-49.54%-1.63
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022(Q3)Jun 30, 2022(Q2)Mar 31, 2022
Total revenue -23.67%18M-8.07%79.2M-6.82%18.93M-3.01%18.89M-4.92%17.8M-14.70%23.59M-11.24%86.16M-13.82%20.32M-9.92%19.48M-7.03%18.72M
Operating revenue -23.67%18M-8.07%79.2M-6.82%18.93M-3.01%18.89M-4.92%17.8M-14.70%23.59M-11.24%86.16M-13.82%20.32M-9.92%19.48M-7.03%18.72M
Cost of revenue
Gross profit
Operating expense -1.32%52.89M3.05%216.41M5.48%49.96M6.89%55.61M8.91%57.25M-7.68%53.6M1.62%210M-17.34%47.37M-6.22%52.02M5.48%52.56M
Selling and administrative expenses 30.10%16.52M16.28%52.89M9.75%13.8M-2.41%12.62M31.52%13.78M33.53%12.7M39.79%45.48M50.42%12.57M52.52%12.93M25.82%10.48M
-General and administrative expense 30.10%16.52M16.28%52.89M9.75%13.8M-2.41%12.62M31.52%13.78M33.53%12.7M39.79%45.48M50.42%12.57M52.52%12.93M25.82%10.48M
Research and development costs -11.08%36.37M-0.61%163.52M3.94%36.17M9.97%42.99M3.28%43.47M-15.75%40.9M-5.51%164.52M-28.91%34.8M-16.82%39.09M1.40%42.09M
Operating profit -16.24%-34.89M-10.79%-137.21M-14.72%-31.03M-12.82%-36.71M-16.56%-39.45M1.30%-30.01M-13.02%-123.84M19.80%-27.05M3.86%-32.54M-13.96%-33.85M
Net non-operating interest income expense -13.70%857K294.91%6.21M139.78%1.51M375.57%1.87M620.39%1.84M993K-22.17%1.57M631K393K255K
Non-operating interest income 332.83%4.3M622.19%11.36M639.14%4.66M883.72%3.87M620.39%1.84M--993K-22.17%1.57M--631K--393K--255K
Non-operating interest expense --3.44M--5.15M--3.15M--2M------0--0--0--0----
Other net income (expense) 407.41%83K
Other non- operating income (expenses) ------------------------407.41%83K------------
Income before tax -17.26%-34.03M-7.21%-131M-12.09%-29.52M-8.39%-34.84M-11.97%-37.61M3.75%-29.02M-13.58%-122.19M21.14%-26.33M3.77%-32.15M-15.22%-33.59M
Income tax -1,729.41%-622K751.50%2.82M-10,171.43%-1.41M1,044.30%4.22M44K5.56%-34K98.49%-433K100.16%14K95.24%-447K0
Net income -15.25%-33.41M-9.91%-133.82M-6.68%-28.11M-23.23%-39.07M-12.10%-37.66M3.75%-28.99M-54.13%-121.76M-7.11%-26.35M-31.95%-31.7M-52.38%-33.59M
Net income continuous Operations -15.25%-33.41M-9.91%-133.82M-6.68%-28.11M-23.23%-39.07M-12.10%-37.66M3.75%-28.99M-54.13%-121.76M-7.11%-26.35M-31.95%-31.7M-52.38%-33.59M
Minority interest income
Net income attributable to the parent company -15.25%-33.41M-9.91%-133.82M-6.68%-28.11M-23.23%-39.07M-12.10%-37.66M3.75%-28.99M-54.13%-121.76M-7.11%-26.35M-31.95%-31.7M-52.38%-33.59M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -15.25%-33.41M-9.91%-133.82M-6.68%-28.11M-23.23%-39.07M-12.10%-37.66M3.75%-28.99M-54.13%-121.76M-7.11%-26.35M-31.95%-31.7M-52.38%-33.59M
Basic earnings per share -13.67%-1.58-7.95%-6.38-4.72%-1.33-21.57%-1.86-9.82%-1.796.08%-1.39-50.77%-5.91-4.10%-1.27-28.57%-1.53-49.54%-1.63
Diluted earnings per share -13.67%-1.58-7.95%-6.38-4.72%-1.33-21.57%-1.86-9.82%-1.796.08%-1.39-50.77%-5.91-4.10%-1.27-28.57%-1.53-49.54%-1.63
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg